Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples